Private Equity Firm EQT Hopes Higher Cash Offer Will Win It Karo Pharma
Private equity firm EQT hopes a higher cash offer for Swedish specialty pharma group Karo Pharma than the one it made two months ago will persuade reluctant shareholders in the biotech to now sell their holdings.